אדריבלסטינה 50 מ"ג PFS

Pays: Israël

Langue: hébreu

Source: Ministry of Health

Ingrédients actifs:

DOXORUBICIN HYDROCHLORIDE 50 MG / 25 ML

Disponible depuis:

PFIZER PHARMACEUTICALS ISRAEL LTD

Code ATC:

L01DB01

forme pharmaceutique:

SOLUTION FOR INJECTION

Mode d'administration:

I.V

Fabriqué par:

ACTAVIS ITALY S.P.A

Groupe thérapeutique:

DOXORUBICIN

indications thérapeutiques:

Adriblastina has been used successfully to produce regression in a variety of neoplastic conditions, such as carcinoma of the breast, lung, bladder, thyroid, and also ovarian carcinomas, bone and soft-tissue sarcomas, Hodgkin's and non- Hodgkin's lymphomas, neuroblastomas, Wilms tumour, acute lymphoblastic leukaemia and acute myeloblastic leukaemia

Date de l'autorisation:

2013-01-01